Roche’s Avastin Fails in Early-Stage Colon Cancer Study

Roche’s top-selling cancer-fighting drug Avastin has hit another roadblock in testing. In a Phase III study, Avastin failed to improve disease-free survival in early-stage colon cancer patients, the pharmaceutical giant reporte…

Johnson & Johnson Plans to Buy Vaccine Maker Crucell

Still in hot water over its “phantom recall” of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Continue reading Johnson & …